cardiovascular disease

Nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin may lessen the adverse effects of air pollution exposure on lung function, a study from Columbia University reports[1]. Researchers analyzed a subset of data collected from a cohort of 2,280 male veterans from the greater Boston area who were given tests to determine their lung function. The average age… Read more

The longest stringent studies of antidepressants’ safety and efficacy only followed patients for only a couple of years. Yet a greater number of Americans are taking antidepressants like Paxil and Prozac for prolonged periods of time. According to data from the National Center for Health Statistics, a quarter of people on the medications have used… Read more

Medical consensus once supported daily use of low dose aspirin to prevent heart attack and stroke in people at increased risk for cardiovascular disease (CVD). But in 2018, three major clinical trials cast doubt on that conventional wisdom, finding few benefits and consistent bleeding risks associated with daily aspirin use. Taken together, the findings led… Read more

Immediately after birth, human infants transition from an environment in which they do not have to breathe to one in which they do. Simultaneous with this transition are major changes in blood circulation that require the cardiovascular and respiratory systems – which are not fully mature at birth – to work together, under the control… Read more

The ways that high levels of a hormone called fibroblast growth factor 23 (FGF23) can reduce brain health have been uncovered by researchers at the Medical University of South Carolina (MUSC). High levels of FGF23 were associated with structural changes in the brain’s frontal lobes. High FGF23 levels are thought to lead to the vascular… Read more